Green Bioactives, a startup that sustainably biomanufactures plant-derived bioactives, has raised £2.6 million ($3.1 million) in seed financing. Their platform can identify, isolate, and cultivate plant vascular stem cells—which can differentiate into distinct plant tissues—for different purposes, allowing the production of bioactives used in pharmaceuticals in a more sustainable and cost-effective way.
Eos Advisory LLP led the funding round, which included investments from Regenerate Ventures’ Agtech Fund in London, Milltrust International Group (offices in London and Singapore), and Scottish Enterprise, which also gave the company advice. The financing will enable the company to grow its management, production, and research team capabilities, allowing the company to demonstrate its biomanufacturing approach at a larger scale.
